← Leaderboards
Yong-Mi Kim
Children'S Hospital Of Los Angeles
$3,673,793
Attributed
$3,673,793
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $402.6K · FY2013–22$500K$375K$250K$125K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$3,673,793 · 1
By mechanism
R01$3,673,793 · 1
Top collaborators
No co-investigators on record.
Most similar at Children'S Hospital Of Los Angeles
Same institution · by research overlap
- Steven David Mittelman$4,374,347
- Etan Orgel$3,586,468
Others in their field
Top investigators on “Pre-B Acute Lymphoblastic Leukemia”
- Carl H. June · University Of Pennsylvania$18,502,263
- Markus Mãschen · Yale University$8,389,279
- Michael A. Farrar · University Of Minnesota$3,405,711
- Nora C Heisterkamp · Children'S Hospital Los Angeles$3,155,761
- Kara Lynn Davis · Stanford University$2,910,165
- Katia Georgopoulos · Massachusetts General Hospital$2,607,375
Research focus
Pre-B Acute Lymphoblastic LeukemiaSamplingLeukemiaLamininRelapseResidual NeoplasmIn VitroIn VivoAdhesionsCellsMass Spectrum AnalysisMalignant NeoplasmsMediatingMouse ModelDrug ResistanceBlocking AntibodiesAdult Acute Lymphocytic LeukemiaBone MarrowBone Marrow CellsAffectAntibodiesCell Adhesion MoleculesChemotherapySignal Transduction
Grant awards (10)
Understanding the niche of minimal residual disease leukemia cells$394,511
R01 · FY2022 · CA · contact PI
Understanding the niche of minimal residual disease leukemia cells$402,563
R01 · FY2021 · CA · contact PI
Understanding the niche of minimal residual disease leukemia cells$402,563
R01 · FY2020 · CA · contact PI
Understanding the niche of minimal residual disease leukemia cells$390,486
R01 · FY2019 · CA · contact PI
Understanding the niche of minimal residual disease leukemia cells$402,563
R01 · FY2018 · CA · contact PI
Investigating the mechanism of ITGA4/6-mediated chemoprotection of ALL cells$335,154
R01 · FY2017 · CA · contact PI
Investigating the mechanism of ITGA4/6-mediated chemoprotection of ALL cells$335,154
R01 · FY2016 · CA · contact PI
Investigating the mechanism of ITGA4/6-mediated chemoprotection of ALL cells$335,154
R01 · FY2015 · CA · contact PI
Investigating the mechanism of ITGA4/6-mediated chemoprotection of ALL cells$328,604
R01 · FY2014 · CA · contact PI
Investigating the mechanism of ITGA4/6-mediated chemoprotection of ALL cells$347,041
R01 · FY2013 · CA · contact PI